3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
9
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Locally Advanced Rectal Cancer
2
Colonic Neoplasms
2
Cervical Cancer Metastatic
2
Breast Neoplasms
2
Adenocarcinoma
2
Turcot syndrome
1
Salivary Gland Neoplasms
1
Recurrence
1
Rectal Cancer Patients
1
Non-squamous Non-small-cell Lung Cancer
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gestational Trophoblastic Disease
1
Esophageal Squamour Cell Cancer
1
Endometrioid Endometrial Cancer
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Primary Liver Cancer
1
Interventions
Cyclophosphamide
22
Dexamethasone
15
Cytarabine
14
venetoclax
13
Vincristine
13
Methotrexate
10
Etoposide
10
Prednisone
9
Doxorubicin
9
Calcium Dobesilate
9
prednylidene
8
dexamethasone acetate
8
dexamethasone 21-phosphate
8
deltacortene
8
auricularum
8
merphos
7
Specimen Handling
7
pegaspargase
6
fludarabine phosphate
6
daratumumab
6
calaspargase pegol
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
fludarabine
5
Stem Cell Transplantation
5
Filgrastim
5
Daunorubicin
5
Bortezomib
5
Biopsy
5
Asparaginase
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
camrelizumab
×
1 year
×
Clear all
No trials found.